and Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery.

The severity of hepatic steatosis is modulated by genetic variants, such as patatin-like phospholipase domain containing 3 () rs738409, transmembrane 6 superfamily member 2 () rs58542926, and membrane-bound O-acyltransferase domain containing 7 () rs641738. Recently, mitochondrial amidoxime reducing component 1 () rs2642438 and hydroxysteroid 17-beta dehydrogenase 13 () rs72613567 polymorphisms were shown to have protective effects on liver diseases. Here, we evaluate these variants in patients undergoing bariatric surgery.

Ultrasound- and biomarker-based assessment of hepatic steatosis in patients with severe obesity.

Introduction: Nonalcoholic fatty liver disease (NAFLD) is a common liver abnormality, but its noninvasive diagnosis in patients with severe obesity remains difficult.

Objectives: Our aim was to investigate the usefulness of the ultrasound‑based hepatorenal index (HRI) technique and 2 biomarker‑based methods, including the hepatic steatosis index (HSI) and NAFLD logit score for the diagnosis of NAFLD in patients referred for bariatric surgery.

Patients And Methods: A total of 162 patients, including 106 with NAFLD, admitted for bariatric surgery participated in the study.

Incisional Surgical Site Infections After Mass and Layered Closure of Upper Abdominal Transverse Incisions: First Results of a Randomized Controlled Trial.

Objective: To compare the early results of mass and layered closure of upper abdominal transverse incisions.

Summary Of Background Data: Contrary to midline incisions, data on closure of transverse abdominal incisions are lacking.

Methods: This is the first analysis of a randomized controlled trial primarily designed to compare mass with layered closure of transverse incisions with respect to incisional hernias.

Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis.

Background The patients with nonalcoholic fatty liver disease demonstrate an increased cardiovascular risk. The adverse influence of liver abnormalities on cardiac function are among many postulated mechanisms behind this association. The aim of the study was to evaluate cardiac morphology and function in patients with morbid obesity referred for bariatric surgery with liver biopsy.

Type 2 Diabetes Remission 5 Years After Laparoscopic Sleeve Gastrectomy: Multicenter Cohort Study.

Purpose: Bariatric surgery is no longer considered only as a weight loss surgery but also a way of treating obesity-related comorbidities such as type 2 diabetes mellitus (T2DM). Short-term T2DM remissions in patients undergoing laparoscopic sleeve gastrectomy (LSG) have been shown, but there are very few reports on the mid-term results. We aimed to assess the remission rate of T2DM in obese patients after LSG throughout 5-year follow-up.